Correction: Metabolically engineered bacteria as light-controlled living therapeutics for anti-angiogenesis tumor therapy

Abstract

Correction for ‘Metabolically engineered bacteria as light-controlled living therapeutics for anti-angiogenesis tumor therapy’ by Xingang Liu et al., Mater. Horiz., 2021, 8, 1454–1460, https://doi.org/10.1039/D0MH01582B.

Associated articles

Article information

Article type
Correction
Submitted
03 Feb 2026
Accepted
03 Feb 2026
First published
13 Feb 2026
This article is Open Access
Creative Commons BY license

Mater. Horiz., 2026, Advance Article

Correction: Metabolically engineered bacteria as light-controlled living therapeutics for anti-angiogenesis tumor therapy

X. Liu, M. Wu, M. Wang, Y. Duan, C. Phan, G. Qi, G. Tang and B. Liu, Mater. Horiz., 2026, Advance Article , DOI: 10.1039/D6MH90022D

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements